Mark Hamilton
Impact in
- Reproductive Medicine top 10%
- Reproductive Health and Technologies
-
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
Papers in
- Oncology 11
- CAR-T cell therapy research 7
- Chemokine receptors and signaling 4
-
- Single-cell and spatial transcriptomics 2
- Co-authors
- Alan Wolfman (2 shared papers)Philipp E. Scherer (3 shared papers)Zhao V. Wang (1 shared paper)Todd Schraw (1 shared paper)Katherine Luby‐Phelps (1 shared paper)Jayoung Kim (1 shared paper)Nils Halberg (1 shared paper)Allan Templeton (2 shared papers)
- Journals
- Blood (9 papers)Oncogene (2 papers)Human Reproduction (2 papers)Hematology/Oncology Clinics of North America (1 paper)Endocrinology (1 paper)
- Partner nations
- United StatesUnited KingdomTaiwan
In The Last Decade
Mark Hamilton
21 papers receiving 546 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Reproductive Medicine 66
- Oncology 147
- Epidemiology 179
- Endocrine and Autonomic Systems 33
- Physiology 113
Countries citing papers authored by Mark Hamilton
This map shows the geographic impact of Mark Hamilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hamilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hamilton more than expected).
Fields of papers citing papers by Mark Hamilton
This network shows the impact of papers produced by Mark Hamilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hamilton. The network helps show where Mark Hamilton may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Hamilton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 169 | |
| 2 | Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy Hit paper breakdown → | 2024 | 93 |
| 3 | 1998 | 66 | |
| 4 | 2009 | 48 | |
| 5 | 1995 | 45 | |
| 6 | 2001 | 43 | |
| 7 | 1993 | 21 | |
| 8 | 2011 | 21 | |
| 9 | 2001 | 11 | |
| 10 | 2020 | 8 | |
| 11 | 2000 | 7 | |
| 12 | 2023 | 6 | |
| 13 | 2022 | 6 | |
| 14 | 2021 | 5 | |
| 15 | 2007 | 2 | |
| 16 | 2003 | 2 | |
| 17 | 2020 | 2 | |
| 18 | 2023 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2022 | 1 |
About Mark Hamilton
Mark Hamilton is a scholar working on Oncology, Molecular Biology, Public Health, Environmental and Occupational Health, Hematology and Reproductive Medicine, having authored 26 papers that have together received 560 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Chemokine receptors and signaling (4 papers), Multiple Myeloma Research and Treatments (4 papers), Cancer Genomics and Diagnostics (3 papers), Reproductive Biology and Fertility (3 papers), Assisted Reproductive Technology and Twin Pregnancy (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Single-cell and spatial transcriptomics (2 papers). The work is most often cited by research in Reproductive Medicine (66 citations), Oncology (147 citations), Epidemiology (179 citations), Endocrine and Autonomic Systems (33 citations) and Physiology (113 citations). Mark Hamilton has collaborated with scholars based in United States, United Kingdom and Taiwan. Frequent co-authors include Alan Wolfman, Philipp E. Scherer, Zhao V. Wang, Todd Schraw, Katherine Luby‐Phelps, Jayoung Kim, Nils Halberg, Allan Templeton, Dorothy I. Mundy and Streamson C. Chua. Their work appears in journals such as Blood, Oncogene, Human Reproduction, Hematology/Oncology Clinics of North America and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.